Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01169_DB06402_nanopub.RAuq6VZTPMW4LZjtrq0pfcDSFoW_79_TjPp1XaudG3l3s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01169_DB06402 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01169_DB06402 label "DDI between Arsenic trioxide and Telavancin - Additive QTc-prolongation may occur. Concomitant therapy should be avoided. [drugbank_resource:DB01169_DB06402]" assertion.
- drugbank_resource:DB01169_DB06402 identifier "drugbank_resource:DB01169_DB06402" assertion.
- drugbank_resource:DB01169_DB06402 title "DDI between Arsenic trioxide and Telavancin - Additive QTc-prolongation may occur. Concomitant therapy should be avoided." assertion.
- drugbank:DB06402 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01169_DB06402 assertion.
- drugbank:DB01169 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01169_DB06402 assertion.